Two independent teams published complementary advances that push protein sequencing toward single‑molecule resolution. Stanford researchers disclosed a scalable method for high‑precision protein decoding in Nature Biotechnology; a separate Nature Biotechnology paper demonstrated single‑molecule peptide sequencing by reverse‑translating peptides into DNA barcodes. Both papers were released March 18, 2026. The Stanford method emphasizes throughput and applicability across complex proteomes, while the reverse‑translation approach converts amino acid signals into DNA readouts compatible with existing sequencers. Together, they tackle two core barriers: sensitivity at the single‑molecule level and compatibility with high‑throughput sequencing workflows. These technical milestones could accelerate biomarker discovery, enable direct proteome‑level diagnostics, and open routes to monitor post‑translational modifications at scale. Commercialization and clinical validation will dictate timing, but the methods establish new technological baselines for molecular proteomics.